Q3 FY24 Earnings Summary

NVIDIA® NVIDIA Collaborates With Genentech to Accelerate Drug Discovery Using Generative Al Genentech is pioneering the use of generative Al to discover and develop new therapeutics and deliver treatments to patients more efficiently NVIDIA will work with Genentech to accelerate Genentech's proprietary algorithms on NVIDIA DGX Cloud Genentech plans to use NVIDIA BioNeMo to help accelerate and optimize their Al drug discovery platform NVIDIA plans to use insights learned from this collaboration to improve its BioNeMo platform BioNeMo is now generally available as a training service

View entire presentation